Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-04

Clinical Trial Update: Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial sponsored by Novartis evaluating valsartan on insulin sensitivity in adults with hypertension and impaired glucose tolerance has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension, Impaired Glucose Tolerance | Phase 4 | Status: COMPLETED